Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2145 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Malignant neoplasm of breast
|
2154 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Neoplasms
|
1571 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.020 | 1.000 | 2 | 2007 | 2019 | ||||||
Adult Pre-B Acute Lymphoblastic Leukemia
|
2 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||
Breast Cancer, Familial
|
90 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Carcinoma of lung
|
995 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Childhood Pre-B Acute Lymphoblastic Leukemia
|
3 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||
Holt-Oram syndrome
|
5 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Leukemia, Myelocytic, Acute
|
247 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 1991 | 1991 | ||||||
Malignant neoplasm of lung
|
1000 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Malignant neoplasm of soft tissue
|
32 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Metastatic osteosarcoma
|
5 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Neoplasm Metastasis
|
327 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Non-Small Cell Lung Carcinoma
|
601 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
8 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Rhabdomyosarcoma
|
17 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Sarcoma
|
36 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Secondary Neoplasm
|
85 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Squamous cell carcinoma of the head and neck
|
171 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1 | 2007 | 2007 | |||||||
Undifferentiated (Embryonal) Sarcoma
|
4 | 0.649 | 0.480 | 17 | 7675209 | missense variant | A/C;G;T | snv | 0.010 | 1.000 | 1 | 2005 | 2005 |